Company intelligence / Profile preview

Divergent Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Divergent Capital is a New York-based pre-seed venture capital firm that leads first rounds for deeply technical and scientific founders building in areas including AI, machine learning, robotics, biotech, logistics, and digital health, with check sizes typically ranging from about $100,000 to $750,000.

Industry: Investors

Beyond the preview

Go deeper on Divergent Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Divergent Capital.

Explore the full profile